Filing Details

Accession Number:
0001213900-19-013045
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-17 21:55:16
Reporting Period:
2019-07-15
Accepted Time:
2019-07-17 21:55:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1444307 Oncosec Medical Inc ONCS Pharmaceutical Preparations (2834) 980573252
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1755469 Alpha Holdings, Inc. Gangnam-Gu Apgujeong-Ro 62-Gil 17-10
Seoul M5 06016
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-07-15 30,000 $2.22 1,521,000 No 4 P Indirect By Alpha Biolabs
Common Stock Acquisiton 2019-07-16 60,000 $2.34 1,581,000 No 4 P Indirect By Alpha Biolabs
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Alpha Biolabs
No 4 P Indirect By Alpha Biolabs
Footnotes
  1. Alpha Biolabs is a wholly-owned subsidiary of Alpha Holdings, Inc.